Physician profile

Gabriel A Rodriguez

Anatomic Pathology & Clinical Pathology · Ashland, KY

NPI 1730101940

$269.16

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

See the full distribution for Anatomic Pathology & Clinical Pathology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$121.26

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Checkpoint Surgical, INC $92.57 2022
Integra Lifesciences Corporation $51.01 2023 Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim
Currax Pharmaceuticals LLC $33.46 2021-2022
Boston Scientific Corporation $26.19 2023 Ams 700 Cxr Rte Kit
Ambu INC. $22.60 2024
Coloplast Corp $21.87 2021
Axonics, INC. $21.46 2023 Axonics

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gabriel A Rodriguez

$269.16

in general payments reported 2019-2025

Years
2021-2024
Top company
Checkpoint Surgical, INC

https://glasscript.com/doctor/896424/gabriel-a-rodriguez

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.